-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Underperform on Amrize, Lowers Price Target to $32

Benzinga·10/09/2026 17:19:02
Listen to the news
RBC Capital analyst Anthony Codling maintains Amrize (NYSE:AMRZ) with a Underperform and lowers the price target from $48 to $32.